Published December 23, 2023 | Version v1
Project deliverable Open

SIMCor. Deliverable 7.8 - Validated virtual cohorts for in-silico trials (TUE, M36)

  • 1. Charité - Universitätsmedizin Berlin

Description

In this report we describe the metadata of the virtual cohorts that will be made publicly available here. In addition, we will specify the validation steps that have been taken to end up with these cohorts (level of validation). Furthermore, we demonstrate the feasibility of using of our virtual cohorts for in-silico trials via simple effect simulations. At the end, we will indicate under which conditions/constraints our cohorts may be used for other applications/use cases (disclaimer).



SIMCor (In-Silico testing and validation of Cardiovascular IMplantable devices) has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 101017578.

Files

SIMCor_D7.8_ Validated virtual cohorts for in-silico trials_TUE_23-12-2023_signed.pdf

Additional details

Funding

European Commission
SIMCOR – In Silico testing and validation of Cardiovascular Implantable devices 101017578

Dates

Accepted
2023-12-23